Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Sanjeev M Bijukchhe"'
Autor:
Andrew J Pollard, Grace Li, Sarah Kelly, Merryn Voysey, Sanjeev M Bijukchhe, Peter J O'Reilly, Katherine Theiss-Nyland, Meeru Gurung, Bhishma Pokhrel, Samita Acharya, Shreekrishna Maharjan, Ashis Shrestha, Bimal Pandey, Mipsang Lama, Ira Shrestha, Agnes Eordogh, Sonu Shrestha, Elaine Shuo Feng, Ganesh Shah, Shrijana Shrestha
Publikováno v:
BMJ Open, Vol 13, Iss 4 (2023)
Introduction Inactivated, viral vector and mRNA vaccines have been used in the Nepali COVID-19 vaccination programme but there is little evidence on the effectiveness of these vaccines in this setting. The aim of this study is to describe COVID-19 va
Externí odkaz:
https://doaj.org/article/53a3c65930df48cdb9014d6f8553070d
Autor:
Aashish Shrestha, Bikram Prasad Gajurel, Ragesh Karn, Rajeev Ojha, Reema Rajbhandari, Niraj Gautam, Sumit Shahi, Pukar Ghimire, Pradeep Panthee, Sanjeev M Bijukchhe
Publikováno v:
Nepal Mediciti Medical Journal. 3:54-58
BACKGROUND The optimal cost benefit of standard plasma exchange (SPE) has not been met where most of the patients do not afford the treatment. As an alternative, low volume plasma exchange (LVPE) is cost-effective than SPE where albumin replacement i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f122a67efbbd6baeddd8510348e6eed3
https://doi.org/10.3126/nmmj.v3i2.52363
https://doi.org/10.3126/nmmj.v3i2.52363
Autor:
Sonu Shrestha, Madhav C. Gautam, P J O’Reilly, Dominic F. Kelly, Imran Ansari, Biplav Shrestha, Merryn Voysey, Sarah Kelly, Sanjeev M Bijukchhe, Baikuntha Acharya, David R. Murdoch, Ganesh Shah, Mamata Maharjan, Rama Kandasamy, Andrew J. Pollard, Raju Pandit, Stephen Thorson, David Goldblatt, Parisa Hariri, Pratistha Maskey, Laxmi Lama, Ruby Basi, Katherine L. O'Brien, Meeru Gurung, Shrijana Shrestha, Manisha K C
Publikováno v:
The Pediatric infectious disease journal. 40(10)
Background: The pneumococcal conjugate vaccine has had a substantial impact on invasive pneumococcal disease. Previously, we compared immunity following vaccination with the 10-valent pneumococcal conjugate vaccine (PCV10) administered at 2 slightly
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7eeaf538c7b428a2fc55520bc82b9d1b
https://pubmed.ncbi.nlm.nih.gov/34292271
https://pubmed.ncbi.nlm.nih.gov/34292271
Autor:
Sarah Kelly, Xinxue Liu, Katherine Theiss-Nyland, Merryn Voysey, Sarah Murphy, Grace Li, Mary Nyantaro, Meeru Gurung, Sudha Basnet, Bhishma Pokhrel, Sanjeev M. Bijukchhe, Agnes Eordogh, Ben Gombe, Ayoub Kakande, Simon Kerridge, Geofrey Kimbugwe, Sylvia Kusemererwa, Lawrence Lubyayi, Henry Luzze, Olga Mazur, Yama F. Mujadidi, Shamim Nabukenya, Walter-Rodney Nagumo, Tryphena Nareeba, Rabiullah Noristani, Peter O’Reilly, Andrew Roberts, Ganesh Shah, Sonu Shrestha, Laxman P. Shrestha, Surya B. Thapa, Freddie M. Kibengo, Arun K. Sharma, Alison Elliott, Shrijana Shrestha, Andrew J. Pollard
Publikováno v:
Trials, Vol 24, Iss 1, Pp 1-9 (2023)
Abstract Background Universal immunisation is the cornerstone of preventive medicine for children, The World Health Organisation (WHO) recommends diphtheria-tetanus-pertussis (DTP) vaccine administered at 6, 10 and 14 weeks of age as part of routine
Externí odkaz:
https://doaj.org/article/638ea8dddc2a4309a79895805cb92c1a